Isala: Clinical Trials

7 trials sponsored by Isala, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 7 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 3, Unknown 2, Active not recruiting 1, Recruiting 1
Phase 32Completed 1, Recruiting 1
Phase 11Completed 1

Follow Isala: new trials by email

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery
Nizaracianine Triflutate, Placebo Comparator - Injury of Ureter During Surgery (Disorder)
Phase 2 / Phase 3RecruitingCuradel Surgical Innovations, Inc.3362024-06-282026-02-23
Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer
S1 + Nal-IRI, Nal-IRI+Leucovorin+5-FU - Metastatic Pancreatic Cancer
Phase 2UnknownAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1222019-12-012021-01-15
Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis
combined radiotherapy and MR-HIFU - Bone Metastases, Bone Neoplasm
Phase 1 / Phase 2CompletedUMC Utrecht102019-04-112024-02-07
Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer
Atezolizumab - Small-cell Lung Cancer
Phase 2Active not recruitingNorwegian University of Science and Technology2122018-07-312026-04-13
Nivolumab Combined With Daratumumab With or Without Low-dose Cyclophosphamide
nivolumab-daratumumab, nivolumab-daratumumab with low-dose cyclophosphamide - Myeloma
Phase 2CompletedAmsterdam UMC, location VUmc622018-02-212024-05-22
Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy
Vemurafenib and Cobimetinib - Melanoma, Malignant, of Soft Parts
Phase 2UnknownRadboud University Medical Center2002017-01-272020-06-05
HaemocomplettanĀ® P During Elective Complex Cardiac Surgery
HaemocomplettanĀ® P, Human albumin (Placebo) - Fibrinogen Deficiency in Complex Cardiac Surgery
Phase 2 / Phase 3CompletedIsala1202011-02-012014-12-16

Conditions studied

Bone Neoplasms (1)  ·  Hemostatic Disorders (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Neoplasms, Plasma Cell (1)  ·  Pain (1)  ·  Pancreatic Neoplasms (1)  ·  Radiation Injuries (1)  ·  Sarcoma, Clear Cell (1)  ·  Small Cell Lung Carcinoma (1)

Interventions

Albumins (1)  ·  Cyclophosphamide (1)  ·  Fibrinogen (1)  ·  S 1 (combination) (1)  ·  Serum Albumin, Human (1)  ·  Sugars (1)  ·  Vemurafenib (1)  ·  ZW800-1 compound (1)  ·  atezolizumab (1)  ·  cobimetinib (1)  ·  irinotecan sucrosofate (1)

Countries

Netherlands (7)  ·  Denmark (1)  ·  Lithuania (1)  ·  Norway (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Alexander L Vahrmeijer, M.D., Ph.D (1)  ·  Arno P Nierich, MD, PhD. (1)  ·  Helena M Verkooijen, MD, PhD (1)  ·  J W Wilmink, MD, PhD (1)  ·  John V Frangioni, M.D., Ph.D. (1)  ·  Niels van de Donk, MD PhD (1)

Results publications

PMID 28241354, PMID 34392637, PMID 41921365

NIH funding

2017 (1)